Sh Pharmaceutical reported CNY3.57B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Jiangsu Hengrui CNY 2.78B 379.11M Sep/2026
Sh Fosun Pharma CNY 1.61B 47.58M Sep/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
WuXi AppTec CNY 10.59B 2.61B Sep/2026